PLATFORM
Intellectual Property
Profectus IP estate
 
Profectus was founded on and continues to build a substantial intellectual property estate that currently includes:
  • U.S. and international patents and patent applications to the original breakthrough discoveries by Wyeth and other third parties which have been licensed or sublicensed to Profectus
  • U.S. and international patents and patent applications to subsequent breakthrough discoveries developed and owned by Profectus
The IP estate includes U.S. and international patents and patent applications claiming first-in-class and best-in-class prophylactic and therapeutic vaccines utilizing:
  • The PBS Vax™ prime/boost platform
  • The VesiculoVax™ platform, both as independent vaccines and as a boost
  • Attenuated VSV and isfahan viral vectors
  • The DNA priming platform
  • Molecular adjuvants
  • Disease-specific constructs
Profectus also has additional extensive experience and know-how supporting its vaccine programs:
  • Licensed from Pfizer
  • Developed by Profectus
© 2017 Profectus BioSciences, Inc. All Rights Reserved.  |  User Login